Canada
Media

News

Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

 

9 - 16of about 40 News
9 - 16of about 40 News
Canadian Students Receive $90,000 in Support from Bayer Fund’s Opportunity Scholarship
READ MORE
Bayer launches Proline® GOLD for premium protection against sclerotinia in canola
READ MORE
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
READ MORE
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
READ MORE
Bayer’s finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetes
READ MORE
Bayer Inc. launches FastTRK, a complimentary clinical testing program for the diagnosis of NTRK gene fusions in TRK fusion cancer patients in Canada
READ MORE
Bayer announces agreements to resolve major legacy Monsanto litigation
READ MORE
Non-metastatic castration resistant prostate cancer treatment NUBEQA® (darolutamide) significantly improves overall survival with a favourable safety profile in men with non-metastatic prostate cancer
READ MORE
9 - 16of about 40 News
9 - 16of about 40 News

Contact us:

Communications Department
Email: mediacanada@bayer.com